New injection for rheumatoid arthritis enters first human safety tests
Disease control
Completed
This early-stage study tested a new biologic drug called SOL-116 in 56 healthy volunteers and people with rheumatoid arthritis. The main goal was to check safety and how the body processes the drug, not whether it works. Participants received a single injection of SOL-116 or a pl…
Phase: PHASE1 • Sponsor: Lipum AB • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC